Endocyte, Inc. (ECYT) Reports Q2 Loss of $0.15

Endocyte, Inc. (NASDAQ: ECYT) reported Q2 EPS of ($0.15), versus $0.35 reported last year. Revenue for the quarter came in at $7.8 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Optimum Communications gets NYSE non-compliance notice over stock price